Seattle-Denver Center of Innovation (COIN)
Paul Hess, MD
- Title: Associate Professor of Medicine at the University of Colorado School of Medicine
- Contact: Paul.Hess@va.gov
- Location: Denver
- University of Colorado webpage
- See Dr. Hess' Dimensions profile that includes: publications, grants, datasets, patents and clinical trials
- Dr. Hess is a cardiologist and health services researcher. His research interests center on the advancement of health care value across the spectrum of value-based outcomes, including improvement in the sustainability of health and health status and reduction of ineffective care. His research has been supported by the American Heart Association and VA HSR&D. He serves as a staff cardiologist at the Rocky Mountain Regional VA Medical Center and an Associate Professor of Medicine at the University of Colorado Anschutz Medical Campus. He received his MD from Emory University School of Medicine and his MHS from Duke University School of Medicine. He underwent residency training in internal medicine at Massachusetts General Hospital and fellowship training in cardiovascular medicine and cardiovascular imaging at Duke University Medical Center.
The following images visualize Dr. Hess' work. The word cloud is drawn from publication titles. The research collaboration map shows research relationships (click the image to enlarge):
|Clinical Research||Health Services|
|Heart Disease - Coronary Heart Disease||Heart Disease|
|Patient Safety||Behavioral and Social Science|
|Clinical Trials and Supportive Activities||Patient Safety|
Kini V, Parks M, Liu W, Waldo SW, Ho PM, Bradley SM, Hess PL. Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System. JAMA Netw Open. 2022 Jun 1;5(6):e2217704. doi: 10.1001/jamanetworkopen.2022.17704.
Learn more about this publication on Dimensions.
Bradley SM, Kaltenbach LA, Xiang K, Amin AP, Hess PL, Maddox TM, Poulose A, Brilakis ES, Sorajja P, Ho PM, Rao SV. Trends in Use and Outcomes of Same-Day Discharge Following Elective Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2021 Aug 9;14(15):1655-1666. doi: 10.1016/j.jcin.2021.05.043.
Hess PL, Gosch KL, Jani SM, Varosy PD, Bradley SM, Maddox TM, Michael Ho P, Virani SS. Use of Oral Anticoagulants in Patients with Valvular Atrial Fibrillation: Findings From the NCDR PINNACLE Registry® Am Heart J. 2021 May 22:S0002-8703(21)00120-4. doi: 10.1016/j.ahj.2021.04.017. Epub ahead of print.
Kovach CP, Hebbe A, O'Donnell CI, Plomondon ME, Hess PL, Rahman A, Mulukutla S, Waldo SW, Valle JA. Comparison of Patients With Nonobstructive Coronary Artery Disease With Versus Without Myocardial Infarction (From the VA Clinical Assessment Reporting and Tracking [CART] Program). Am J Cardiol. 2021 Feb 1:S0002-9149(21)00086-2. doi: 10.1016/j.amjcard.2021.01.015. Epub ahead of print. PMID: .
Gu K, Mahtta D, Kaneria A, Sharedalal P, Dennis B, Song Y, Wei X, Khalid U, Hess P, Cho SH, Virani SS. Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR® PINNACLE Registry. Int J Cardiol. 2021 Apr 15;329:209-216. doi: 10.1016/j.ijcard.2020.12.064. Epub 2021 Jan 5.
Kini V, Hess PL, Liu W, Grunwald G, Ho PM, Bradley SM. Association Between Elective Percutaneous Coronary Intervention Appropriateness and Publicly Reported Outcomes. Circ Cardiovasc Qual Outcomes. 2020 Nov 9. doi: 10.1161/CIRCOUTCOMES.120.007421. Epub ahead of print.
Salahuddin T, Richardson V, McNeal DM, Henderson K, Hess PL, Raghavan S, Saxon DR, Valle JA, Waldo SW, Ho PM, Schwartz GG. Potential unrealized mortality benefit of glucagon-like peptide-1 receptor agonists and sodium-glucose co-transport-2 inhibitors: A report from the Veterans Health Administration Clinical Assessment, Reporting and Tracking program. Diabetes Obes Metab. 2021 Jan;23(1):97-105. doi: 10.1111/dom.14193. Epub 2020 Oct 3.
Hess PL, Kini V, Liu W, Roldan P, Autruong P, Grunwald GK, O'Donnell C, Doll JA, Ho PM, Bradley SM. Appropriateness of Percutaneous Coronary Interventions in Patients With Stable Coronary Artery Disease in US Department of Veterans Affairs Hospitals From 2013 to 2015. JAMA Netw Open. 2020 Apr 1;3(4):e203144. doi: 10.1001/jamanetworkopen.2020.3144.
Hess PL, Matlock DD, Al-Khatib SM. Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults. Clin Cardiol. 2020 Feb;43(2):187-195. doi: 10.1002/clc.23315. Epub 2019 Dec 23.
Hess PL, Sheng S, Matsouaka R, DeVore AD, Heidenreich PA, Yancy CW, Bhatt DL, Allen LA, Peterson PN, Ho PM, Lewis WR, Hernandez AF, Fonarow GC, Piccini JP. Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). Am J Cardiol. 2020 Mar 15;125(6):894-900. doi: 10.1016/j.amjcard.2019.12.025. Epub 2019 Dec 30.PMID: 31980141
Rymer JA, O'Donnell CI, Plomondon ME, Hess PL, Donahue M, Hebert PL, Shroff A, Swaminathan RV, Waldo SW, Seto AH, Helfrich CD, Rao SV. Same-day discharge among patients undergoing elective PCI: Insights from the VA CART Program. Am Heart J. 2019 Dec;218:75-83. doi: 10.1016/j.ahj.2019.09.003. Epub 2019 Sep 12.
Grants & Funding
How Do High-Value Hospitals Succeed in Heart Failure Transitional Care? A Multi-Methods Proposal
Funder: American Heart Association (AHA)